Japan Gene Therapy Market Report by Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide Gene, Deficiency, Growth Factors, Receptors, and Others), Vector Type (Viral Vector, Non-Viral Techniques), Delivery Method (In-Vivo Gene Therapy, Ex-Vivo Gene Therapy), Application (Oncological Disorders, Rare diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Others), and Region 2024-2032

Japan Gene Therapy Market Report by Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide Gene, Deficiency, Growth Factors, Receptors, and Others), Vector Type (Viral Vector, Non-Viral Techniques), Delivery Method (In-Vivo Gene Therapy, Ex-Vivo Gene Therapy), Application (Oncological Disorders, Rare diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112025A9327

1   Preface 
2   Scope and Methodology 

    2.1    Objectives of the Study 
    2.2    Stakeholders 
    2.3    Data Sources 
        2.3.1    Primary Sources 
        2.3.2    Secondary Sources 
    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach 
        2.4.2    Top-Down Approach 
    2.5    Forecasting Methodology 
3   Executive Summary 
4   Japan Gene Therapy Market - Introduction 

    4.1    Overview 
    4.2    Market Dynamics 
    4.3    Industry Trends 
    4.4    Competitive Intelligence 
5   Japan Gene Therapy Market Landscape 
    5.1    Historical and Current Market Trends (2018-2023) 
    5.2    Market Forecast (2024-2032) 
6   Japan Gene Therapy Market - Breakup by Gene Type 
    6.1    Antigen
        6.1.1 Overview 
        6.1.2 Historical and Current Market Trends (2018-2023) 
        6.1.3 Market Forecast (2024-2032) 
    6.2    Cytokine
        6.2.1 Overview 
        6.2.2 Historical and Current Market Trends (2018-2023) 
        6.2.3 Market Forecast (2024-2032) 
    6.3    Tumor Suppressor
        6.3.1 Overview 
        6.3.2 Historical and Current Market Trends (2018-2023) 
        6.3.3 Market Forecast (2024-2032) 
    6.4    Suicide Gene
        6.4.1 Overview 
        6.4.2 Historical and Current Market Trends (2018-2023) 
        6.4.3 Market Forecast (2024-2032)
    6.5    Deficiency
        6.5.1 Overview 
        6.5.2 Historical and Current Market Trends (2018-2023) 
        6.5.3 Market Forecast (2024-2032) 
    6.6    Growth Factors
        6.6.1 Overview 
        6.6.2 Historical and Current Market Trends (2018-2023) 
        6.6.3 Market Forecast (2024-2032) 
    6.7    Receptors
        6.7.1 Overview 
        6.7.2 Historical and Current Market Trends (2018-2023) 
        6.7.3 Market Forecast (2024-2032) 
    6.8    Others
        6.8.1 Overview 
        6.8.2 Historical and Current Market Trends (2018-2023) 
        6.8.3 Market Forecast (2024-2032) 
7   Japan Gene Therapy Market - Breakup by Vector Type
    7.1    Viral Vector 
        7.1.1 Overview 
        7.1.2 Historical and Current Market Trends (2018-2023)
        7.1.3 Market Segmentation
           7.1.3.1 Adenoviruses
           7.1.3.2 Lentiviruses
           7.1.3.3 Retroviruses
           7.1.3.4 Adeno-Associated Virus
           7.1.3.5 Herpes Simplex Virus
           7.1.3.6 Poxvirus
           7.1.3.7 Vaccinia Virus
           7.1.3.8 Others
        7.1.4 Market Forecast (2024-2032) 
    7.2    Non-Viral Techniques
        7.2.1 Overview 
        7.2.2 Historical and Current Market Trends (2018-2023) 
        7.2.3 Market Segmentation
           7.2.3.1 Naked and Plasmid Vectors
           7.2.3.2 Gene Gun
           7.2.3.3 Electroporation
           7.2.3.4 Lipofection
          7.2.3.5 Others
        7.2.4 Market Forecast (2024-2032) 
8   Japan Gene Therapy Market - Breakup by Delivery Method 
    8.1    In-Vivo Gene Therapy
        8.1.1 Overview 
        8.1.2 Historical and Current Market Trends (2018-2023) 
        8.1.3 Market Forecast (2024-2032) 
    8.2    Ex-Vivo Gene Therapy
        8.2.1 Overview 
        8.2.2 Historical and Current Market Trends (2018-2023) 
        8.2.3 Market Forecast (2024-2032) 
9   Japan Gene Therapy Market - Breakup by Application 
    9.1    Oncological Disorders
        9.1.1 Overview 
        9.1.2 Historical and Current Market Trends (2018-2023) 
        9.1.3 Market Forecast (2024-2032) 
    9.2    Rare Diseases
        9.2.1 Overview 
        9.2.2 Historical and Current Market Trends (2018-2023) 
        9.2.3 Market Forecast (2024-2032) 
    9.3    Cardiovascular Diseases
        9.3.1 Overview 
        9.3.2 Historical and Current Market Trends (2018-2023) 
        9.3.3 Market Forecast (2024-2032) 
    9.4    Neurological Disorders
        9.4.1 Overview 
        9.4.2 Historical and Current Market Trends (2018-2023) 
        9.4.3 Market Forecast (2024-2032) 
    9.5    Infectious Disease
        9.5.1 Overview 
        9.5.2 Historical and Current Market Trends (2018-2023) 
        9.5.3 Market Forecast (2024-2032) 
    9.6    Others
        9.6.1 Overview 
        9.6.2 Historical and Current Market Trends (2018-2023) 
        9.6.3 Market Forecast (2024-2032) 
10   Japan Gene Therapy Market – Breakup by Region
    10.1    Kanto Region
        10.1.1 Overview 
        10.1.2 Historical and Current Market Trends (2018-2023) 
        10.1.3 Market Breakup by Gene Type 
        10.1.4 Market Breakup by Vector Type 
        10.1.5 Market Breakup by Delivery Method 
        10.1.6 Market Breakup by Application 
        10.1.7 Key Players 
        10.1.8 Market Forecast (2024-2032) 
    10.2    Kinki Region
        10.2.1 Overview 
        10.2.2 Historical and Current Market Trends (2018-2023) 
        10.2.3 Market Breakup by Gene Type 
        10.2.4 Market Breakup by Vector Type 
        10.2.5 Market Breakup by Delivery Method 
        10.2.6 Market Breakup by Application 
        10.2.7 Key Players 
        10.2.8 Market Forecast (2024-2032) 
    10.3    Central/ Chubu Region
        10.3.1 Overview 
        10.3.2 Historical and Current Market Trends (2018-2023) 
        10.3.3 Market Breakup by Gene Type 
        10.3.4 Market Breakup by Vector Type 
        10.3.5 Market Breakup by Delivery Method 
        10.3.6 Market Breakup by Application 
        10.3.7 Key Players 
        10.3.8 Market Forecast (2024-2032) 
    10.4    Kyushu-Okinawa Region 
        10.4.1 Overview 
        10.4.2 Historical and Current Market Trends (2018-2023) 
        10.4.3 Market Breakup by Gene Type 
        10.4.4 Market Breakup by Vector Type 
        10.4.5 Market Breakup by Delivery Method 
        10.4.6 Market Breakup by Application 
        10.4.7 Key Players 
        10.4.8 Market Forecast (2024-2032) 
    10.5    Tohoku Region
        10.5.1 Overview 
        10.5.2 Historical and Current Market Trends (2018-2023) 
        10.5.3 Market Breakup by Gene Type 
        10.5.4 Market Breakup by Vector Type 
        10.5.5 Market Breakup by Delivery Method 
        10.5.6 Market Breakup by Application 
        10.5.7 Key Players 
        10.5.8 Market Forecast (2024-2032) 
    10.6    Chugoku Region
        10.6.1 Overview 
        10.6.2 Historical and Current Market Trends (2018-2023) 
        10.6.3 Market Breakup by Gene Type 
        10.6.4 Market Breakup by Vector Type 
        10.6.5 Market Breakup by Delivery Method 
        10.6.6 Market Breakup by Application 
        10.6.7 Key Players 
        10.6.8 Market Forecast (2024-2032)
    10.7    Hokkaido Region
        10.7.1 Overview 
        10.7.2 Historical and Current Market Trends (2018-2023) 
        10.7.3 Market Breakup by Gene Type 
        10.7.4 Market Breakup by Vector Type 
        10.7.5 Market Breakup by Delivery Method 
        10.7.6 Market Breakup by Application 
        10.7.7 Key Players 
        10.7.8 Market Forecast (2024-2032) 
    10.8    Shikoku Region
        10.8.1 Overview 
        10.8.2 Historical and Current Market Trends (2018-2023) 
        10.8.3 Market Breakup by Gene Type 
        10.8.4 Market Breakup by Vector Type 
        10.8.5 Market Breakup by Delivery Method 
        10.8.6 Market Breakup by Application 
        10.8.7 Key Players 
        10.8.8 Market Forecast (2024-2032)
11   Japan Gene Therapy Market – Competitive Landscape 
    11.1    Overview 
    11.2    Market Structure 
    11.3    Market Player Positioning 
    11.4    Top Winning Strategies 
    11.5    Competitive Dashboard 
    11.6    Company Evaluation Quadrant 
12   Profiles of Key Players 
    12.1    Company A
        12.1.1 Business Overview 
        12.1.2 Services Offered 
        12.1.3 Business Strategies 
        12.1.4 SWOT Analysis 
        12.1.5 Major News and Events 
    12.2    Company B 
        12.2.1 Business Overview 
        12.2.2 Services Offered 
        12.2.3 Business Strategies 
        12.2.4 SWOT Analysis 
        12.2.5 Major News and Events 
    12.3    Company C 
        12.3.1 Business Overview 
        12.3.2 Services Offered 
        12.3.3 Business Strategies 
        12.3.4 SWOT Analysis 
        12.3.5 Major News and Events 
    12.4    Company D
        12.4.1 Business Overview 
        12.4.2 Services Offered 
        12.4.3 Business Strategies 
        12.4.4 SWOT Analysis 
        12.4.5 Major News and Events 
    12.5    Company E 
        12.5.1 Business Overview 
        12.5.2 Services Offered 
        12.5.3 Business Strategies 
        12.5.4 SWOT Analysis 
        12.5.5 Major News and Events
 
Company names have not been provided here as this is a sample TOC. Complete list to be provided in the final report. 
 
13   Japan Gene Therapy Market - Industry Analysis 

    13.1    Drivers, Restraints, and Opportunities 
        13.1.1 Overview 
        13.1.2 Drivers 
        13.1.3 Restraints 
        13.1.4 Opportunities 
    13.2   Porters Five Forces Analysis 
        13.2.1 Overview 
        13.2.2 Bargaining Power of Buyers 
        13.2.3 Bargaining Power of Suppliers 
        13.2.4 Degree of Competition 
        13.2.5 Threat of New Entrants 
        13.2.6 Threat of Substitutes 
    13.3    Value Chain Analysis 
14   Appendix

Japan Gene Therapy Market Report by Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide Gene, Deficiency, Growth Factors, Receptors, and Others), Vector Type (Viral Vector, Non-Viral Techniques), Delivery Method (In-Vivo Gene Therapy, Ex-Vivo Gene Therapy), Application (Oncological Disorders, Rare diseases, Cardiovascular Diseases, Neurological Disorders, Infectious Disease, and Others), and Region 2024-2032
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials